Histone deacetylase mediates the decrease in drebrin cluster density induced by amyloid beta oligomers

Yuta Ishizuka1, Hideo Shimizu1, Eiko Takagi1

  • 1Department of Neurobiology and Behavior, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.

Insights

Alzheimer

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Dendritic spine defects are implicated in cognitive disorders like Alzheimer's disease (AD).
  • Amyloid beta (Aβ) toxicity, particularly from soluble oligomers (ADDLs), contributes to synaptic dysfunction.
  • Drebrin, an actin-binding protein at dendritic spines, is reduced in AD and Aβ-exposed neurons.

Purpose of the Study:

  • To investigate the role of histone deacetylase (HDAC) activity in ADDL-induced synaptic defects.
  • To examine if HDAC inhibition can prevent ADDL-induced loss of drebrin clusters at dendritic spines.

Main Methods:

  • Utilized suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor, in cultured neurons exposed to ADDLs.
  • Quantified drebrin cluster density along dendrites and assessed histone acetylation levels.
  • Evaluated the impact of SAHA on dendritic protrusions and drebrin cluster density in control and ADDL-treated neurons.

Main Results:

  • ADDLs reduced drebrin cluster density without altering overall drebrin expression.
  • SAHA treatment increased histone acetylation and prevented the ADDL-induced decrease in drebrin cluster density.
  • SAHA did not affect drebrin cluster or dendritic protrusion density in control neurons, suggesting stabilization rather than promotion.

Conclusions:

  • HDAC activity is involved in ADDL-induced synaptic defects, specifically impacting drebrin localization.
  • Histone acetylation regulation is crucial for maintaining dendritic spine actin dynamics under cellular stress like ADDL exposure.
  • HDAC inhibition offers a potential therapeutic avenue for synaptic dysfunction in conditions like Alzheimer's disease.